Contact the Editorial Desk

Editorial correspondence

Raw Wholesale Peptides welcomes correspondence on the research record: a citation quoted inaccurately, a regulatory reference that has gone out of date, or a peer-reviewed study about AOD-9604, Tesamorelin, or MOTS-c that should be added to the references page. Corrections that improve the accuracy of the digest are the most useful messages we receive.

The most actionable notes specify three things: the page they refer to, the exact passage in question, and the supporting citation — a DOI or PubMed ID wherever possible.

Editorial mailbox: editors@rawwholesalepeptides.com

What this desk cannot do

So that no message goes unanswered for the wrong reason, several things fall outside what this site can address. Raw Wholesale Peptides is a literature digest, not a clinic or a vendor, so we cannot:

• Advise on, recommend, or comment on human use of any peptide discussed here.
• Suggest a dose, schedule, or route of administration for any individual.
• Diagnose a condition or judge whether a particular research finding applies to a particular person.
• Sell, source, recommend, or help locate any compound from any supplier.
• Answer requests from athletes subject to anti-doping rules about using these compounds — AOD-9604 and Tesamorelin are both prohibited under WADA S2.

Readers seeking medical guidance should consult a licensed clinician in their own jurisdiction. Responses to editorial correspondence are not guaranteed and may be delayed; the mailbox is monitored intermittently.